跳转至内容
Merck
CN

主要文件

查看所有文档

NXF-10

Natrix® Q 小试装置

Natrix® Q Pilot (15 mL), pack of 1 device

别名:

Natrix® Q膜吸附器

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
41115711
eCl@ss:
32011308
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Natrix® Q 小试装置,

ligand

quaternary amine

Quality Level

400

description

Natrix® Q Pilot

product line

Natrix®

parameter

75-375 mL/min flow rate

bed H

0.5 mm

bed volume

15 mL

matrix active group

Macroporous polymer

pore size

0.4 μm pore size

capacity

3 g binding capacity (BSA)(per device)

separation technique

strong anion exchange

shipped in

ambient

General description

Natrix®(Q)层析膜采用革命性的三维大孔水凝胶结构，提供了高密度的吸附位点和快速传质，其吸附能力超过了树脂填料柱，兼具传统膜吸附剂常见的高流速。性能和速度兼备，搭配一次性、即插即用设计为生物分子纯化提供了低风险、可放大的高效解决方案。

Natrix®(Q)层析膜是一种高生产率强阴离子交换膜，专为生物分子纯化而设计。该独特的 Natrix® Q层析膜是一种多孔聚丙烯酰胺水凝胶，含有高密度的季铵 (Q) 结合基团，这些基团直接聚合在惰性大孔膜支架内。互连的孔隙结构和高官能团密度可实现快流速（几秒的停留时间），并在极高负载下具有出色的通量，同时在各种缓冲条件下保持优异的杂质减少率。Natrix®(Q)层析膜设计可提高任何生物工艺设计的生产率、灵活性、工艺稳健性和经济性。Natrix®(Q) Pilot是中等规模的层析膜装置，用于验证和调整操作参数。可用于小规模的临床和商业化生产。
标称单抗精纯能力：150 g

膜结构：有褶的

每个包装 1 台设备
强阴离子交换层析膜设计，可纯化具有高密度季胺配体的生物分子，可在高负载下实现快流速和高通量，同时保持优异的杂质减少率

Features and Benefits

Natrix® Q 膜吸附器为用户提供：

  • 高密度季胺结合位点可实现快速传质
  • 即使在快流速下也具有高结合能力
  • 一次性、即插即用设备格式的性能和速度相结合，可实现低风险、可扩展的高效生物分子纯化解决方案。

Packaging

双袋装

Legal Information

NATRIFLO is a trademark of Merck KGaA, Darmstadt, Germany
NATRIX is a registered trademark of Merck KGaA, Darmstadt, Germany

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

商品

Developing and Manufacturing Attenuated Viral Vaccines

Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.

Robust, load independent viral clearance in monoclonal antibody purification with Natrix® Q chromatography membrane

Membrane adsorbers are a cost-effective, robust, single-use solution for monoclonal antibody polishing

Purification of Extracellular Vesicles with Eshmuno® Q Resin and Natrix® Q Membrane

Separation and purification of subpopulations of extracellular vesicles (EVs) using Eshmuno® Q anion exchange resin and Natrix® Q membrane chromatography.

查看所有文章

相关内容

病毒疫苗生产

通过合作进行量身定制的病毒疫苗生产，应对病毒特有的挑战。

Adenovirus Vaccine Manufacturing Process

This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.

Mochao Zhao et al.
Vaccine, 37(36), 5491-5503 (2018-04-09)
Affinity chromatography is among the most powerful separation techniques, achieving the finest separation with high yields even in the most challenging feed streams. Incorporating affinity chromatography in vaccine purification has long been attempted by researchers to improve unit yield and
Renaud Jacquemart et al.
Computational and structural biotechnology journal, 14, 309-318 (2016-08-30)
The current processing paradigm of large manufacturing facilities dedicated to single product production is no longer an effective approach for best manufacturing practices. Increasing competition for new indications and the launch of biosimilars for the monoclonal antibody market have put
Ying Hou et al.
Biotechnology progress, 31(4), 974-982 (2015-05-29)
Protein A chromatography is widely employed for the capture and purification of monoclonal antibodies (mAbs). Because of the high cost of protein A resins, there is a significant economic driving force to seek new downstream processing strategies. Membrane chromatography has

全球贸易项目编号

货号GTIN
NXF-1004054839460784